Annual Working Capital
$240.49 M
-$64.11 M-21.05%
December 31, 2024
Summary
- As of March 9, 2025, ARCT annual working capital is $240.49 million, with the most recent change of -$64.11 million (-21.05%) on December 31, 2024.
- During the last 3 years, ARCT annual working capital has fallen by -$38.93 million (-13.93%).
- ARCT annual working capital is now -42.50% below its all-time high of $418.27 million, reached on December 31, 2020.
Performance
ARCT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$240.49 M
-$20.87 M-7.98%
December 31, 2024
Summary
- As of March 9, 2025, ARCT quarterly working capital is $240.49 million, with the most recent change of -$20.87 million (-7.98%) on December 31, 2024.
- Over the past year, ARCT quarterly working capital has dropped by -$14.80 million (-5.80%).
- ARCT quarterly working capital is now -42.50% below its all-time high of $418.27 million, reached on December 31, 2020.
Performance
ARCT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ARCT Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -21.1% | -5.8% |
3 y3 years | -13.9% | +40.8% |
5 y5 years | +354.1% | +40.8% |
ARCT Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -21.1% | at low | -28.1% | +40.8% |
5 y | 5-year | -42.5% | +354.1% | -42.5% | +471.1% |
alltime | all time | -42.5% | >+9999.0% | -42.5% | >+9999.0% |
Arcturus Therapeutics Holdings Working Capital History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $240.49 M(-21.0%) | $240.49 M(-8.0%) |
Sep 2024 | - | $261.36 M(+2.4%) |
Jun 2024 | - | $255.29 M(-1.9%) |
Mar 2024 | - | $260.36 M(-14.5%) |
Dec 2023 | $304.60 M(+10.2%) | $304.60 M(-0.3%) |
Sep 2023 | - | $305.58 M(+3.6%) |
Jun 2023 | - | $294.90 M(-11.8%) |
Mar 2023 | - | $334.43 M(+21.0%) |
Dec 2022 | $276.35 M(-1.1%) | $276.35 M(+61.8%) |
Sep 2022 | - | $170.83 M(-14.1%) |
Jun 2022 | - | $198.76 M(-9.5%) |
Mar 2022 | - | $219.70 M(-21.4%) |
Dec 2021 | $279.42 M(-33.2%) | $279.42 M(-7.7%) |
Sep 2021 | - | $302.73 M(-17.6%) |
Jun 2021 | - | $367.27 M(-11.9%) |
Mar 2021 | - | $416.66 M(-0.4%) |
Dec 2020 | $418.27 M(+689.7%) | $418.27 M(+46.2%) |
Sep 2020 | - | $286.09 M(+140.5%) |
Jun 2020 | - | $118.95 M(+182.5%) |
Mar 2020 | - | $42.11 M(-20.5%) |
Dec 2019 | $52.97 M | $52.97 M(-8.2%) |
Sep 2019 | - | $57.72 M(+23.0%) |
Jun 2019 | - | $46.92 M(+113.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $21.99 M(-24.8%) |
Dec 2018 | $29.25 M(-26.6%) | $29.25 M(+40.6%) |
Sep 2018 | - | $20.80 M(-11.2%) |
Jun 2018 | - | $23.43 M(-41.2%) |
Dec 2017 | $39.83 M(+1007.3%) | $39.83 M(+4.5%) |
Sep 2017 | - | $38.11 M(-5.8%) |
Jun 2017 | - | $40.46 M(-8.0%) |
Mar 2017 | - | $43.98 M(+1122.8%) |
Dec 2016 | $3.60 M(-92.8%) | $3.60 M(-92.7%) |
Sep 2016 | - | $49.33 M(-4.1%) |
Jun 2016 | - | $51.45 M(-2.3%) |
Mar 2016 | - | $52.65 M(+5.3%) |
Dec 2015 | $49.99 M(+153.1%) | $49.99 M(+43.7%) |
Sep 2015 | - | $34.80 M(-9.8%) |
Jun 2015 | - | $38.56 M(+95.2%) |
Dec 2014 | $19.75 M(-59.3%) | $19.75 M(-23.3%) |
Sep 2014 | - | $25.75 M(-26.9%) |
Jun 2014 | - | $35.21 M(-16.3%) |
Mar 2014 | - | $42.07 M(-13.4%) |
Dec 2013 | $48.58 M(-8362.2%) | $48.58 M(+163.4%) |
Sep 2013 | - | $18.44 M(-13.6%) |
Jun 2013 | - | $21.34 M(-3728.7%) |
Dec 2012 | -$588.00 K(-231.3%) | -$588.00 K |
Dec 2011 | $448.00 K | - |
FAQ
- What is Arcturus Therapeutics Holdings annual working capital?
- What is the all time high annual working capital for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual working capital year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly working capital?
- What is the all time high quarterly working capital for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly working capital year-on-year change?
What is Arcturus Therapeutics Holdings annual working capital?
The current annual working capital of ARCT is $240.49 M
What is the all time high annual working capital for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual working capital is $418.27 M
What is Arcturus Therapeutics Holdings annual working capital year-on-year change?
Over the past year, ARCT annual working capital has changed by -$64.11 M (-21.05%)
What is Arcturus Therapeutics Holdings quarterly working capital?
The current quarterly working capital of ARCT is $240.49 M
What is the all time high quarterly working capital for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly working capital is $418.27 M
What is Arcturus Therapeutics Holdings quarterly working capital year-on-year change?
Over the past year, ARCT quarterly working capital has changed by -$14.80 M (-5.80%)